This Ascendis Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday -

Benzinga
Benzinga kaynağında aç
<?xml encoding="utf-8" ?>

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Ascendis Pharma A/S (NASDAQ: ASND ) with a Buy rating and announced a price target of $345. Ascendis Pharma closed at $250.25 on Wednesday. See how other analysts view this stock . Truist Securities analyst Miller Jump initiated coverage on DigitalOcean Holdings Inc (NYSE: DOCN ) with a Buy rating and announced a price target of $175. DigitalOcean shares closed at $114.99 on Wednesday. See how other analysts view this stock . HC Wainwright & Co. analyst Emily Bodnar initiated coverage on Odyssey Therapeutics, Inc. (NASDAQ: ODTX ) with a Buy rating and announced a price target of $44. Odyssey Therapeutics closed at $25.62 on Wednesday. See how other analysts view this stock .

Considering buying ASND stock? Here’s what analysts think:

Photo via Shutterstock

Trending

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here .


Posted In: Markets Trading Ideas News Analyst Ratings Initiation Top Initiations